The neuropathic pain market studied is anticipated to register a CAGR of 5.5% during the forecast period.
The neuropathic pain market is moderately competitive and consists of a few major players. Companies like Grünenthal, Mallinckrodt Pharmaceuticals, GlaxoSmithKline Plc, J Pfizer, Inc., Cipla, Inc., Glenmark, Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, among others, hold a substantial market share in the market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook